Perhaps the strongest proof links HIV and an increased risk of heart disease. Some AIDS medications raise that risk. But in research published for the AIDS meeting, scientists at Massachusetts General Hospital uncovered another justification. They scanned the arteries of individuals with and without HIV, and found the HIV patients had more inflammation inside their arteries, putting them at risk for the type of clots that trigger heart attacks. That’s even though the HIV patients experienced their virus well-managed and weren’t that outdated – – their average age group was 52, the researchers reported in the Journal of the American Medical Association. HIV triggers body-wide swelling as a person’s disease fighting capability tries to fight the virus, an activity that persists and will quietly damage organs despite having good medications, CDC’s Fenton said.Kaiser Family members Foundation. Kaiser Health Information, an editorially independent information service, is a scheduled plan of the Kaiser Family Foundation, a nonpartisan health care policy research company unaffiliated with Kaiser Permanente.. BIOCITECH, Seine-Saint-Denis CCI announce winners of 1st BIOCITECH Funding Day BIOCITECH, the town complex for health care and biotechnology businesses and the Seine-Saint-Denis Chamber of Commerce and Industry , announce the three winners of the 1st BIOCITECH Financing Day today. In the first place, 25 of the firms that authorized on the site were selected to produce a poster display of their business to traders. Nine of these were given the chance to pitch at a plenary program. To conclude the full day, a panel produced up of people from each round-table program chosen three winners: Phycopharma: development prize, creates medication candidates predicated on microalgae for the treating resistant tumors Kallistem: seed-financing prize, evolves innovative cell tradition technology in reproductive biology HPE Substances: emergence prize, aims to build up nutrition and heath elements from meals processing of snails.